Results 241 to 250 of about 103,309 (254)
Some of the next articles are maybe not open access.

Genetic characterization of MYD88-mutated lymphoplasmacytic lymphoma in comparison with MYD88-mutated chronic lymphocytic leukemia

Leukemia, 2016
MYD88 (myeloid differentiation primary response 88) is mutated in the majority of Waldenström macroglobulinemia/lymphoplasmacytic lymphoma (LPL); but also, albeit less frequently, in other B-cell malignancies, including chronic lymphocytic leukemia (CLL).
C, Baer   +4 more
openaire   +2 more sources

Characterization of MYD88 mutated Lymphoplasmacytic Lymphoma in Comparison to MYD88 mutated Chronic Lymphocytic Leukemia

Blood, 2015
Abstract Introduction: MYD88 (Myeloid Differentiation Primary Response 88) mutations are the most common genetic aberration in Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma (LPL). Since the initial description of MYD88 mutations in LPL, the detection has gained great importance in diagnosing the disease.
Constance Regina Baer   +4 more
openaire   +1 more source

Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P mutation

Blood
Abstract Myeloid differentiation primary response protein 88 (MYD88) is a key adaptor molecule in the signaling pathways of toll-like receptor and interleukin-1 receptor. A somatic mutation resulting in a leucine-to-proline change at position 265 of the MYD88 protein (MYD88 L265P) is one of the most prevalent ...
Wei Li   +8 more
openaire   +2 more sources

MyD88 - poster

2009
Vânia Martins   +7 more
openaire   +1 more source

MyD88

2012
openaire   +1 more source

MyD88

2011
openaire   +1 more source

MyD88

2008
openaire   +1 more source

MyD88

2018
openaire   +1 more source

MYD88-5

2018
openaire   +1 more source

MyD88-5

2012
openaire   +1 more source

Home - About - Disclaimer - Privacy